Symposium sets new direction for infectious diseases research at Imperial
Infectious diseases experts shared their latest work at an annual research symposium hosted at Imperial’s Hammersmith Campus last month.
EAVI2020 Announces Start of New HIV Vaccine Trial
The European AIDS Vaccine Initiative (EAVI2020) are getting closer to developing a protective vaccine against HIV with clinical trials now underway.
HIV remission achieved in second patient
A second person has experienced sustained remission from HIV-1 after ceasing treatment, reports a paper led by UCL and Imperial College London.
‘Test and Treat’ reduces new HIV infections by a third in African communities
Results from largest ever HIV prevention trial suggest strategy could make a significant contribution to controlling epidemic.
Smartphones could help diagnose infectious diseases in sub-Saharan Africa
A new Imperial-led review has outlined how health workers could use existing phones to predict and curb the spread of infectious diseases.
Imperial launches its first public health online degree
The Global Master of Public Health, developed alongside Coursera, is Imperial's first fully-online degree in the health field.
Imperial takes the lead on a global study of HIV-associated liver cancer
Research from the Liver Cancer Research Group at Imperial has shed new light on the natural course of liver cancer in people living with HIV.
Leading MP hosted by Imperial Scientist at IAVI Human Immunology Laboratory
Norman Lamb MP visited the International AIDS Vaccine Initiative (IAVI) Human Immunology Laboratory at Chelsea and Westminster Hospital last week.
Anti-inflammatory drug reduces key complication risk in HIV-positive TB patients
Trial finds that prednisone can reduce the risk of TB-IRIS – a serious complication seen in HIV-positive tuberculosis (TB) patients.
Killer immune cells fend off viruses with a helping hand from key proteins
New research reveals how killer cell immunoglobin-like receptors (KIRs) can strengthen the immune system’s response to HIV-1, HCV and HTLV-1 infection
